Article: Purdue Pharma L.P. Announces Signing of Consent Judgment Ending OxyContin(R) Tablets Patent Lawsuit with Teva Pharmaceuticals.

Teva admits Purdue Pharma's OxyContin patents are valid, enforceable and infringed

STAMFORD, Conn., Oct. 16 /PRNewswire/ -- The patent litigation between Purdue Pharma L.P. of Stamford, Connecticut and Teva Pharmaceuticals USA, Inc. of North Wales, Pennsylvania concerning certain Purdue Pharma patents on OxyContin(R) (oxycodone HCl controlled-release) Tablets ended on Thursday, October 12 with the signing of a Consent Judgment

in the United States District Court for the Southern District of New York. In the Consent Judgment, Teva admits that Purdue Pharma's OxyContin patents are valid, enforceable and infringed by Teva's extended-release oxycodone ...

Related newspaper, magazine, and journal articles:

 
 
Newsweek Harper's Magazine The Washington Post Chicago Tribune Crain's Chicago Business PRNewswire Pediatric News The Nation Advertising Age The Economist (US) A FREE trial gives you access to over 80 million articles! Access over 6,500 publications with a FREE trial!